Drug data last refreshed 16h ago · AI intelligence enriched 3w ago
RID Mousse is a topical aerosol pediculicide combining pyrethrins (natural insecticide) and piperonyl butoxide (synergist) for treating head lice infestations. The formulation works by disrupting the nervous system of lice through neurotoxic mechanisms. It is indicated for pediculosis capitis (head lice) in patients of various ages.
LOE-stage product with moderate competitive pressure (30%) signals waning commercial growth and potential team restructuring or focus shift to line extensions.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Working on RID Mousse offers limited career growth given its LOE-approaching status and zero linked job openings. This role is best suited for early-career professionals seeking OTC/consumer health experience or mid-career professionals managing legacy products through portfolio optimization.
Worked on RID MOUSSE at Bayer? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.